Cargando…
Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells
Resulting from a various etiologies, the most notable remains ischemia; heart failure (HF) manifests as the common end pathway of many cardiovascular processes and remains among the top causes for hospitalization and a major cause of morbidity and mortality worldwide. Current pharmacologic treatment...
Autores principales: | Pandey, Amitabh C., Lancaster, Jordan J., Harris, David T., Goldman, Steven, Juneman, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748110/ https://www.ncbi.nlm.nih.gov/pubmed/29391871 http://dx.doi.org/10.1155/2017/9640108 |
Ejemplares similares
-
Surgical treatment for heart failure: cell-based therapy with engineered tissue
por: Lancaster, Jordan J., et al.
Publicado: (2019) -
New Therapeutics for Heart Failure: Focusing on cGMP Signaling
por: Mangmool, Supachoke, et al.
Publicado: (2023) -
Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart Failure
por: Chinyere, Ikeotunye Royal, et al.
Publicado: (2021) -
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
por: Mengstie, Misganaw Asmamaw, et al.
Publicado: (2022) -
Editorial: Molecular and cellular mechanisms of heart failure: pathophysiology, pathogenesis and therapeutics
por: Lal, Sean, et al.
Publicado: (2023)